Cargando…
Vitamin K Contents in Liver Tissue of Hepatocellular Carcinoma Patients
Serum protein induced in vitamin K absence‐II (PIVKA‐II) is used as a tumor marker because it increases at a notably higher rate in patients with hepatocellular carcinoma. To clarify the mechanism causing the elevation of serum PIVKA‐II, we measured the contents of vitamins K(1) (phylloquinone, PK)...
Autores principales: | Miyakawa, Takayuki, Kajiwara, Yasuhiro, Shirahata, Akira, Okamoto, Kohji, Itoh, Hideaki, Ohsato, Keiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926228/ https://www.ncbi.nlm.nih.gov/pubmed/10744046 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00861.x |
Ejemplares similares
-
Vitamin K Deficiency Bleeding in Infancy
por: Araki, Shunsuke, et al.
Publicado: (2020) -
Vitamin A Content in Human Liver
por: Działoszyński, L., et al.
Publicado: (1947) -
Content and Bioaccessibility of Vitamin K (Phylloquinone and Menaquinones) in Cheese
por: Jensen, Marie Bagge, et al.
Publicado: (2021) -
Efficacy and safety of sorafenib plus vitamin K treatment for hepatocellular carcinoma: A phase II, randomized study
por: Haruna, Yoshimichi, et al.
Publicado: (2021) -
Molecular Mechanism of Matrine from Sophora alopecuroides in the Reversing Effect of Multi-Anticancer Drug Resistance in K562/ADR Cells
por: Chen, Zhi, et al.
Publicado: (2019)